.png)
Lancet Market by Type and End User - Global Industry Analysis & Forecast to 2027
Published On : July 2019 Pages : 161 Category: Medical Devices Report Code : HC074283
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Lancet Market by Type (Pressure Activated Safety Lancet, Personal Lancet, Push Button Safety Lancet, Side Button Safety Lancet) End User (Diagnostic Centers and Pathology Laboratories, Research and Academic Laboratories, Hospitals and Clinics, Home Diagnostics, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Lancet Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Lancets are being utilized for diabetes/glucose test, tests in newborn children, heel-stick screening tests, just as for scarred crisis patients or seriously consumed patients. The components driving the market development incorporate developing rate of infectious and non-infectious maladies, expanding pervasiveness of diabetes, and rising tendency towards home consideration and home diagnostics.
Drivers and Restraints
With the expanding predominance of diabetes, the interest for lancets is required to be huge, in this way bringing about the expanding interest for gadgets and items to screen and control diabetes, in the long run prompting expanded utilization of lancets. Nonetheless, the hazard related with blood transfusion is anticipated to impede the market development during the conjecture time frame.
Regional Insights
The Americas held a generous offer in the worldwide lancet market inferable from the ascent in the commonness of diabetes and the expanding requirement for a diabetes diagnosis.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Bayer AG
- Sarstedt AG and Co.
- Abbott Laboratories
- Greiner Bio-One International GmbH
- Terumo Corporation
- HTL-STREFA S.A.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd
- Improve Medical Instruments Co. Ltd
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Lancet Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Pressure Activated Safety Lancet
o Personal Lancet
o Push Button Safety Lancet
o Side Button Safety Lancet
· Lancet Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Diagnostic Centers and Pathology Laboratories
o Research and Academic Laboratories
o Hospitals and Clinics
o Home Diagnostics
o Others
· Lancet Market, By Key Players
o Bayer AG
o Sarstedt AG and Co.
o Abbott Laboratories
o Greiner Bio-One International GmbH
o Terumo Corporation
o HTL-STREFA S.A.
o Becton, Dickinson and Company
o F. Hoffmann-La Roche Ltd
o Improve Medical Instruments Co. Ltd
· Lancet Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Lancet Market, By Country
o U.S. Lancet Market
o Canada Lancet Market
o Mexico Lancet Market
o Europe
§ Europe Lancet Market, By Country
o Germany Lancet Market
o UK Lancet Market
o France Lancet Market
o Russia Lancet Market
o Italy Lancet Market
o Rest of Europe Lancet Market
o Asia-Pacific
§ Asia-Pacific Lancet Market, By Country
o China Lancet Market
o Japan Lancet Market
o South Korea Lancet Market
o India Lancet Market
o Southeast Asia Lancet Market
o Rest of Asia-Pacific Lancet Market
o South America
§ South America Lancet Market
o Brazil Lancet Market
o Argentina Lancet Market
o Columbia Lancet Market
o Rest of South America Lancet Market
o Middle East and Africa
§ Middle East and Africa Lancet Market
o Saudi Arabia Lancet Market
o UAE Lancet Market
o Egypt Lancet Market
o Nigeria Lancet Market
o South Africa Lancet Market
o Rest of MEA Lancet Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Lancet Market, By Type
5.1. Introduction
5.2. Global Lancet Revenue and Market Share by Type (2017-2027)
5.2.1. Global Lancet Revenue and Revenue Share by Type (2017-2027)
5.3. Pressure Activated Safety Lancet
5.3.1. Global Pressure Activated Safety Lancet Revenue and Growth Rate (2017-2027)
5.4. Personal Lancet
5.4.1. Global Personal Lancet Revenue and Growth Rate (2017-2027)
5.5. Push Button Safety Lancet
5.5.1. Global Push Button Safety Lancet Revenue and Growth Rate (2017-2027)
5.6. Side Button Safety Lancet
5.6.1. Global Side Button Safety Lancet Revenue and Growth Rate (2017-2027)
6. Lancet Market, By End User
6.1. Introduction
6.2. Global Lancet Revenue and Market Share by End User (2017-2027)
6.2.1. Global Lancet Revenue and Revenue Share by End User (2017-2027)
6.3. Diagnostic Centers and Pathology Laboratories
6.3.1. Global Diagnostic Centers and Pathology Laboratories Revenue and Growth Rate (2017-2027)
6.4. Research and Academic Laboratories
6.4.1. Global Research and Academic Laboratories Revenue and Growth Rate (2017-2027)
6.5. Hospitals and Clinics
6.5.1. Global Hospitals and Clinics Revenue and Growth Rate (2017-2027)
6.6. Home Diagnostics
6.6.1. Global Home Diagnostics Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Lancet Market, By Region
7.1. Introduction
7.2. Global Lancet Revenue and Market Share by Regions
7.2.1. Global Lancet Revenue by Regions (2017-2027)
7.3. North America Lancet by Countries
7.3.1. North America Lancet Revenue and Growth Rate (2017-2027)
7.3.2. North America Lancet Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Lancet by Countries
7.4.1. Europe Lancet Revenue and Growth Rate (2017-2027)
7.4.2. Europe Lancet Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Lancet by Countries
7.5.1. Asia-Pacific Lancet Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Lancet Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Lancet by Countries
7.6.1. South America Lancet Revenue and Growth Rate (2017-2027)
7.6.2. South America Lancet Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Lancet by Countries
7.7.1. Middle East and Africa Lancet Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Lancet Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Bayer AG
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Sarstedt AG and Co.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Abbott Laboratories
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Greiner Bio-One International GmbH
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Terumo Corporation
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. HTL-STREFA S.A.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Becton, Dickinson and Company
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. F. Hoffmann-La Roche Ltd
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Improve Medical Instruments Co. Ltd
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Lancet Market Forecast (2017-2027)
9.1. Global Lancet Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Lancet Market Forecast by Regions (2017-2027)
9.2.1. North America Lancet Market Forecast (2017-2027)
9.2.1.1. United States Lancet Market Forecast (2017-2027)
9.2.1.2. Canada Lancet Market Forecast (2017-2027)
9.2.1.3. Mexico Lancet Market Forecast (2017-2027)
9.2.2. Europe Lancet Market Forecast (2017-2027)
9.2.2.1. Germany Lancet Market Forecast (2017-2027)
9.2.2.2. France Lancet Market Forecast (2017-2027)
9.2.2.3. UK Lancet Market Forecast (2017-2027)
9.2.2.4. Russia Lancet Market Forecast (2017-2027)
9.2.2.5. Italy Lancet Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Lancet Market Forecast (2017-2027)
9.2.3. Asia-Pacific Lancet Market Forecast (2017-2027)
9.2.3.1. China Lancet Market Forecast (2017-2027)
9.2.3.2. Japan Lancet Market Forecast (2017-2027)
9.2.3.3. Korea Lancet Market Forecast (2017-2027)
9.2.3.4. India Lancet Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Lancet Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Lancet Market Forecast (2017-2027)
9.2.4. South America Lancet Market Forecast (2017-2027)
9.2.4.1. Brazil Lancet Market Forecast (2017-2027)
9.2.4.2. Argentina Lancet Market Forecast (2017-2027)
9.2.4.3. Columbia Lancet Market Forecast (2017-2027)
9.2.4.4. Rest of South America Lancet Market Forecast (2017-2027)
9.2.5. Middle East and Africa Lancet Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Lancet Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Lancet Market Forecast (2017-2027)
9.2.5.3. Egypt Lancet Market Forecast (2017-2027)
9.2.5.4. Nigeria Lancet Market Forecast (2017-2027)
9.2.5.5. South Africa Lancet Market Forecast (2017-2027)
9.2.5.6. Turkey Lancet Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Lancet Market Forecast (2017-2027)
9.3. Lancet Market Forecast by Type (2017-2027)
9.3.1. Lancet Forecast by Type (2017-2027)
9.3.2. Lancet Market Share Forecast by Type (2017-2027)
9.4. Lancet Market Forecast by End User (2017-2027)
9.4.1. Lancet Forecast by End User (2017-2027)
9.4.2. Lancet Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Lancet Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Lancet Revenue and Revenue Share by Type (2017-2018)
Figure Global Pressure Activated Safety Lancet Revenue and Growth Rate (2017-2018)
Figure Global Personal Lancet Revenue and Growth Rate (2017-2018)
Figure Global Push Button Safety Lancet Revenue and Growth Rate (2017-2018)
Figure Global Side Button Safety Lancet Revenue and Growth Rate (2017-2018)
Table Global Lancet Revenue and Revenue Share by End User (2017-2018)
Figure Global Diagnostic Centers and Pathology Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Research and Academic Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Hospitals and Clinics Revenue and Growth Rate (2017-2018)
Figure Global Home Diagnostics Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Lancet Revenue by Regions (2017-2018)
Figure North America Lancet Growth Rate (2017-2018)
Figure North America Lancet Revenue and Growth Rate (2017-2018)
Figure North America Lancet by Countries (2017-2018)
Figure North America Lancet Revenue (Million USD) by Countries (2017-2018)
Figure United States Lancet Growth Rate (2017-2018)
Figure United States Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Lancet Growth Rate (2017-2018)
Figure Canada Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Lancet Growth Rate (2017-2018)
Figure Mexico Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Lancet Growth Rate (2017-2018)
Figure Europe Lancet Revenue and Growth Rate (2017-2018)
Figure Europe Lancet by Countries (2017-2018)
Figure Europe Lancet Revenue (Million USD) by Countries (2017-2018)
Figure Germany Lancet Growth Rate (2017-2018)
Figure Germany Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Lancet Growth Rate (2017-2018)
Figure France Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Lancet Growth Rate (2017-2018)
Figure UK Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Lancet Growth Rate (2017-2018)
Figure Russia Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Lancet Growth Rate (2017-2018)
Figure Italy Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Lancet Growth Rate (2017-2018)
Figure Rest of Europe Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Lancet Growth Rate (2017-2018)
Figure Asia-Pacific Lancet Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Lancet by Countries (2017-2018)
Figure Asia-Pacific Lancet Revenue (Million USD) by Countries (2017-2018)
Figure China Lancet Growth Rate (2017-2018)
Figure China Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Lancet Growth Rate (2017-2018)
Figure Japan Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Lancet Growth Rate (2017-2018)
Figure Korea Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Lancet Growth Rate (2017-2018)
Figure India Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Lancet Growth Rate (2017-2018)
Figure Southeast Asia Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Lancet Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Lancet Growth Rate (2017-2018)
Figure South America Lancet Revenue and Growth Rate (2017-2018)
Figure South America Lancet by Countries (2017-2018)
Figure South America Lancet Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Lancet Growth Rate (2017-2018)
Figure Brazil Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Lancet Growth Rate (2017-2018)
Figure Argentina Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Lancet Growth Rate (2017-2018)
Figure Columbia Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Lancet Growth Rate (2017-2018)
Figure Rest of South America Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Lancet Growth Rate (2017-2018)
Figure Middle East and Africa Lancet Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Lancet by Countries (2017-2018)
Figure Middle East and Africa Lancet Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Lancet Growth Rate (2017-2018)
Figure Saudi Arabia Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Lancet Growth Rate (2017-2018)
Figure United Arab Emirates Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Lancet Growth Rate (2017-2018)
Figure Egypt Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Lancet Growth Rate (2017-2018)
Figure Nigeria Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Lancet Growth Rate (2017-2018)
Figure South Africa Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Lancet Growth Rate (2017-2018)
Figure Turkey Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Lancet Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Lancet Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bayer AG Lancet Financial Overview
Table Sarstedt AG and Co. Lancet Financial Overview
Table Abbott Laboratories Lancet Financial Overview
Table Greiner Bio-One International GmbH Lancet Financial Overview
Table Terumo Corporation Lancet Financial Overview
Table HTL-STREFA S.A. Lancet Financial Overview
Table Becton, Dickinson and Company Lancet Financial Overview
Table F. Hoffmann-La Roche Ltd Lancet Financial Overview
Table Improve Medical Instruments Co. Ltd Lancet Financial Overview
Figure Global Lancet Revenue (Millions USD) and Growth Rate (2018-2025)
Table Lancet Market Forecast by Regions (2018-2025)
Figure North America Lancet Market Forecast (2018-2025)
Figure United States Lancet Market Forecast (2018-2025)
Figure Canada Lancet Market Forecast (2018-2025)
Figure Mexico Lancet Market Forecast (2018-2025)
Figure Europe Lancet Market Forecast (2018-2025)
Figure Germany Lancet Market Forecast (2018-2025)
Figure France Lancet Market Forecast (2018-2025)
Figure UK Lancet Market Forecast (2018-2025)
Figure Russia Lancet Market Forecast (2018-2025)
Figure Italy Lancet Market Forecast (2018-2025)
Figure Rest of Europe Lancet Market Forecast (2018-2025)
Figure Asia-Pacific Lancet Market Forecast (2018-2025)
Figure China Lancet Market Forecast (2018-2025)
Figure Japan Lancet Market Forecast (2018-2025)
Figure Korea Lancet Market Forecast (2018-2025)
Figure India Lancet Market Forecast (2018-2025)
Figure Southeast Asia Lancet Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Lancet Market Forecast (2018-2025)
Figure South America Lancet Market Forecast (2018-2025)
Figure Brazil Lancet Market Forecast (2018-2025)
Figure Argentina Lancet Market Forecast (2018-2025)
Figure Columbia Lancet Market Forecast (2018-2025)
Figure Rest of South America Lancet Market Forecast (2018-2025)
Figure Middle East and Africa Lancet Market Forecast (2018-2025)
Figure Saudi Arabia Lancet Market Forecast (2018-2025)
Figure United Arab Emirates Lancet Market Forecast (2018-2025)
Figure Egypt Lancet Market Forecast (2018-2025)
Figure Nigeria Lancet Market Forecast (2018-2025)
Figure South Africa Lancet Market Forecast (2018-2025)
Figure Turkey Lancet Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Lancet Market Forecast (2018-2025)
Figure Global Lancet Forecast by Type (2018-2025)
Figure Global Lancet Market Share Forecast by Type (2018-2025)
Figure Global Lancet Forecast by Type (2018-2025)
Figure Global Lancet Forecast by End User (2018-2025)
Figure Global Lancet Market Share Forecast by End User (2018-2025)
Figure Global Lancet Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|